Kyverna Therapeutics Closes $85 Million Series B Financing

EMERYVILLE, Calif., January 26, 2022– FLG client, Kyverna Therapeutics (“Kyverna”), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, has announced it has closed an oversubscribed $85 million Series B financing round led by Northpond Ventures. FLG partner Jonathan Wolter assisted as CFO. Additional investors…Read More

Read More
ONI Microscopy Platform Closes $75M Series B Financing

San Diego and Oxford, England – January 20, 2022 – FLG client, ONI, a spinout of Oxford University, has announced the close of a $75M Series B fundraising round led by ARCH Venture Partners and Casdin Capital, LLC, with participation from new investors Section 32, ARTIS Ventures, Vertical Venture Partners,…Read More

Read More
Jumio Completes 4Stop Acquisition

January 19, 2022 – Jumio, the leading provider of AI-powered end-to-end identity orchestration, eKYC and AML solutions, today announced the completion of its acquisition of 4Stop, the leading data marketplace and orchestration hub for KYB, KYC, compliance and fraud prevention. FLG partner Ken Chow assisted. Full press release is here.

Read More
Kedalion Therapeutics Secures Series B Funding and Announces Signing of Option to Acquire Agreement

November 15, 2021 – Kedalion Therapeutics is pleased to announce the completion of its Series B financing led by Novartis and involving a combination of new and existing investors. The Novartis investment includes an Exclusive Option to Acquire the company and its AcuStream™ technology. This agreement follows a Feasibility Study…Read More

Read More
Level Home, Inc. Acquires Dwelo, Inc. and Raises $100M+ C Round

November 10, 2021 – Level Home, Inc., today announced that it has acquired and merged with Dwelo, Inc., the leading provider of SaaS-based smart device management platforms for multifamily properties. With the addition of Dwelo, Level now offers a world-class smart home platform of integrated hardware and software solutions for all residential…Read More

Read More